Details for New Drug Application (NDA): 217427
✉ Email this page to a colleague
The generic ingredient in ESOMEPRAZOLE MAGNESIUM is esomeprazole magnesium. There are seventy-four drug master file entries for this compound. One hundred and thirteen suppliers are listed for this compound. Additional details are available on the esomeprazole magnesium profile page.
Summary for 217427
| Tradename: | ESOMEPRAZOLE MAGNESIUM |
| Applicant: | Granules |
| Ingredient: | esomeprazole magnesium |
| Patents: | 0 |
Pharmacology for NDA: 217427
| Mechanism of Action | Cytochrome P450 2C19 Inhibitors Proton Pump Inhibitors |
Suppliers and Packaging for NDA: 217427
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium | CAPSULE, DELAYED REL PELLETS;ORAL | 217427 | ANDA | Granules Pharmaceuticals Inc. | 70010-133 | 70010-133-03 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70010-133-03) |
| ESOMEPRAZOLE MAGNESIUM | esomeprazole magnesium | CAPSULE, DELAYED REL PELLETS;ORAL | 217427 | ANDA | Granules Pharmaceuticals Inc. | 70010-133 | 70010-133-09 | 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (70010-133-09) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | EQ 20MG BASE | ||||
| Approval Date: | Oct 18, 2023 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE, DELAYED REL PELLETS;ORAL | Strength | EQ 40MG BASE | ||||
| Approval Date: | Oct 18, 2023 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
